Annual EBIT
-$21.32 M
+$23.90 M+52.85%
December 31, 2023
Summary
- As of February 26, 2025, XGN annual earnings before interest & taxes is -$21.32 million, with the most recent change of +$23.90 million (+52.85%) on December 31, 2023.
- During the last 3 years, XGN annual EBIT has fallen by -$7.12 million (-50.14%).
- XGN annual EBIT is now -319.21% below its all-time high of -$5.09 million, reached on December 31, 2018.
Performance
XGN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$4.47 M
-$2.06 M-85.62%
September 30, 2024
Summary
- As of February 26, 2025, XGN quarterly earnings before interest & taxes is -$4.47 million, with the most recent change of -$2.06 million (-85.62%) on September 30, 2024.
- Over the past year, XGN quarterly EBIT has increased by +$392.00 thousand (+8.07%).
- XGN quarterly EBIT is now -813.29% below its all-time high of -$489.00 thousand, reached on December 31, 2018.
Performance
XGN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$14.66 M
+$392.00 K+2.60%
September 30, 2024
Summary
- As of February 26, 2025, XGN TTM earnings before interest & taxes is -$14.66 million, with the most recent change of +$392.00 thousand (+2.60%) on September 30, 2024.
- Over the past year, XGN TTM EBIT has increased by +$15.70 million (+51.72%).
- XGN TTM EBIT is now -1293.25% below its all-time high of -$1.05 million, reached on September 30, 2018.
Performance
XGN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
XGN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +52.9% | +8.1% | +51.7% |
| 3 y3 years | -50.1% | +31.3% | +28.8% |
| 5 y5 years | -319.2% | -22.0% | -4.3% |
XGN EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +52.9% | -85.6% | +68.2% | at high | +67.6% |
| 5 y | 5-year | -150.2% | +52.9% | -85.6% | +68.2% | -72.0% | +67.6% |
| alltime | all time | -319.2% | +52.9% | -813.3% | +68.2% | -1293.3% | +67.6% |
Exagen EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.47 M(+85.6%) | -$14.66 M(-2.6%) |
| Jun 2024 | - | -$2.41 M(-14.4%) | -$15.05 M(-11.9%) |
| Mar 2024 | - | -$2.81 M(-43.5%) | -$17.08 M(-19.9%) |
| Dec 2023 | -$21.32 M(-52.9%) | -$4.97 M(+2.4%) | -$21.32 M(-29.8%) |
| Sep 2023 | - | -$4.86 M(+9.4%) | -$30.36 M(-7.9%) |
| Jun 2023 | - | -$4.44 M(-37.0%) | -$32.98 M(-22.6%) |
| Mar 2023 | - | -$7.05 M(-49.7%) | -$42.60 M(-5.8%) |
| Dec 2022 | -$45.22 M(+88.0%) | -$14.01 M(+87.3%) | -$45.22 M(+20.8%) |
| Sep 2022 | - | -$7.48 M(-46.8%) | -$37.45 M(+2.7%) |
| Jun 2022 | - | -$14.06 M(+45.3%) | -$36.47 M(+29.5%) |
| Mar 2022 | - | -$9.67 M(+55.1%) | -$28.16 M(+17.1%) |
| Dec 2021 | -$24.05 M(+69.4%) | -$6.24 M(-4.0%) | -$24.05 M(+16.9%) |
| Sep 2021 | - | -$6.50 M(+13.1%) | -$20.57 M(+16.0%) |
| Jun 2021 | - | -$5.75 M(+3.3%) | -$17.73 M(+20.5%) |
| Mar 2021 | - | -$5.56 M(+101.4%) | -$14.71 M(+3.6%) |
| Dec 2020 | -$14.20 M | -$2.76 M(-24.6%) | -$14.20 M(+1.1%) |
| Sep 2020 | - | -$3.66 M(+34.2%) | -$14.05 M(+11.3%) |
| Jun 2020 | - | -$2.73 M(-46.0%) | -$12.62 M(+7.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$5.05 M(+93.3%) | -$11.77 M(+38.1%) |
| Dec 2019 | -$8.52 M(+67.6%) | -$2.61 M(+17.0%) | -$8.52 M(+33.2%) |
| Sep 2019 | - | -$2.23 M(+19.0%) | -$6.40 M(+22.6%) |
| Jun 2019 | - | -$1.88 M(+4.0%) | -$5.22 M(+56.1%) |
| Mar 2019 | - | -$1.80 M(+268.7%) | -$3.34 M(+117.0%) |
| Dec 2018 | -$5.09 M(-78.1%) | -$489.00 K(-53.5%) | -$1.54 M(+46.5%) |
| Sep 2018 | - | -$1.05 M(-30.9%) | -$1.05 M(-92.7%) |
| Dec 2017 | -$23.23 M(+61.0%) | - | - |
| Dec 2015 | -$14.43 M(+19.7%) | -$1.52 M(-25.0%) | -$14.43 M(-1.1%) |
| Sep 2015 | - | -$2.03 M(-76.3%) | -$14.59 M(-11.7%) |
| Jun 2015 | - | -$8.57 M(+271.9%) | -$16.52 M(+46.7%) |
| Mar 2015 | - | -$2.31 M(+36.7%) | -$11.26 M(-6.6%) |
| Dec 2014 | -$12.05 M(-3.7%) | -$1.69 M(-57.4%) | -$12.05 M(-26.7%) |
| Sep 2014 | - | -$3.96 M(+19.4%) | -$16.45 M(+13.1%) |
| Jun 2014 | - | -$3.31 M(+6.9%) | -$14.55 M(+29.5%) |
| Mar 2014 | - | -$3.10 M(-49.1%) | -$11.23 M(+38.1%) |
| Dec 2013 | -$12.51 M(+83.5%) | -$6.09 M(+197.4%) | -$8.13 M(+297.4%) |
| Sep 2013 | - | -$2.05 M | -$2.05 M |
| Dec 2012 | -$6.82 M | - | - |
FAQ
- What is Exagen annual earnings before interest & taxes?
- What is the all time high annual EBIT for Exagen?
- What is Exagen annual EBIT year-on-year change?
- What is Exagen quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Exagen?
- What is Exagen quarterly EBIT year-on-year change?
- What is Exagen TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Exagen?
- What is Exagen TTM EBIT year-on-year change?
What is Exagen annual earnings before interest & taxes?
The current annual EBIT of XGN is -$21.32 M
What is the all time high annual EBIT for Exagen?
Exagen all-time high annual earnings before interest & taxes is -$5.09 M
What is Exagen annual EBIT year-on-year change?
Over the past year, XGN annual earnings before interest & taxes has changed by +$23.90 M (+52.85%)
What is Exagen quarterly earnings before interest & taxes?
The current quarterly EBIT of XGN is -$4.47 M
What is the all time high quarterly EBIT for Exagen?
Exagen all-time high quarterly earnings before interest & taxes is -$489.00 K
What is Exagen quarterly EBIT year-on-year change?
Over the past year, XGN quarterly earnings before interest & taxes has changed by +$392.00 K (+8.07%)
What is Exagen TTM earnings before interest & taxes?
The current TTM EBIT of XGN is -$14.66 M
What is the all time high TTM EBIT for Exagen?
Exagen all-time high TTM earnings before interest & taxes is -$1.05 M
What is Exagen TTM EBIT year-on-year change?
Over the past year, XGN TTM earnings before interest & taxes has changed by +$15.70 M (+51.72%)